Logo image of USAS

AMERICAS GOLD AND SILVER COR (USAS) Stock Fundamental Analysis

NYSEARCA:USAS - NYSE Arca - CA03062D1006 - Common Stock - Currency: USD

0.604  -0.01 (-1.93%)

After market: 0.6139 +0.01 (+1.64%)

Fundamental Rating

2

Overall USAS gets a fundamental rating of 2 out of 10. We evaluated USAS against 152 industry peers in the Metals & Mining industry. Both the profitability and financial health of USAS have multiple concerns. While showing a medium growth rate, USAS is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year USAS has reported negative net income.
USAS had a negative operating cash flow in the past year.
In the past 5 years USAS always reported negative net income.
In the past 5 years USAS always reported negative operating cash flow.
USAS Yearly Net Income VS EBIT VS OCF VS FCFUSAS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M

1.2 Ratios

Looking at the Return On Assets, with a value of -23.33%, USAS is doing worse than 80.26% of the companies in the same industry.
The Return On Equity of USAS (-84.09%) is worse than 86.18% of its industry peers.
Industry RankSector Rank
ROA -23.33%
ROE -84.09%
ROIC N/A
ROA(3y)-21.76%
ROA(5y)-29.6%
ROE(3y)-67.54%
ROE(5y)-77.36%
ROIC(3y)N/A
ROIC(5y)N/A
USAS Yearly ROA, ROE, ROICUSAS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

The Gross Margin of USAS (17.42%) is comparable to the rest of the industry.
USAS's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for USAS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 17.42%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y43.19%
USAS Yearly Profit, Operating, Gross MarginsUSAS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

More info and screens

1

2. Health

2.1 Basic Checks

USAS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for USAS has been increased compared to 1 year ago.
USAS has more shares outstanding than it did 5 years ago.
USAS has a better debt/assets ratio than last year.
USAS Yearly Shares OutstandingUSAS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
USAS Yearly Total Debt VS Total AssetsUSAS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

Based on the Altman-Z score of -2.34, we must say that USAS is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of USAS (-2.34) is worse than 86.18% of its industry peers.
USAS has a Debt/Equity ratio of 0.44. This is a healthy value indicating a solid balance between debt and equity.
USAS has a Debt to Equity ratio of 0.44. This is in the lower half of the industry: USAS underperforms 73.03% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF N/A
Altman-Z -2.34
ROIC/WACCN/A
WACC9.28%
USAS Yearly LT Debt VS Equity VS FCFUSAS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

USAS has a Current Ratio of 0.59. This is a bad value and indicates that USAS is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.59, USAS is doing worse than 90.13% of the companies in the same industry.
USAS has a Quick Ratio of 0.59. This is a bad value and indicates that USAS is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of USAS (0.43) is worse than 90.13% of its industry peers.
Industry RankSector Rank
Current Ratio 0.59
Quick Ratio 0.43
USAS Yearly Current Assets VS Current LiabilitesUSAS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

6

3. Growth

3.1 Past

USAS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -12.50%.
USAS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.87%.
Measured over the past years, USAS shows a quite strong growth in Revenue. The Revenue has been growing by 11.40% on average per year.
EPS 1Y (TTM)-12.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)11.87%
Revenue growth 3Y30.77%
Revenue growth 5Y11.4%
Sales Q2Q%12.26%

3.2 Future

USAS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.57% yearly.
USAS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 25.66% yearly.
EPS Next Y80.36%
EPS Next 2Y41.42%
EPS Next 3Y27.16%
EPS Next 5Y20.57%
Revenue Next Year46%
Revenue Next 2Y25.66%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
USAS Yearly Revenue VS EstimatesUSAS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M
USAS Yearly EPS VS EstimatesUSAS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2027 2028 0 -0.2 -0.4 -0.6 -0.8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

USAS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for USAS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
USAS Price Earnings VS Forward Price EarningsUSAS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
USAS Per share dataUSAS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1

4.3 Compensation for Growth

A more expensive valuation may be justified as USAS's earnings are expected to grow with 27.16% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3Y27.16%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for USAS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AMERICAS GOLD AND SILVER COR

NYSEARCA:USAS (4/25/2025, 8:04:00 PM)

After market: 0.6139 +0.01 (+1.64%)

0.604

-0.01 (-1.93%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)03-27 2025-03-27/bmo
Earnings (Next)05-13 2025-05-13
Inst Owners20.1%
Inst Owner Change59.73%
Ins Owners9.33%
Ins Owner Change0%
Market Cap378.71M
Analysts80
Price Target0.87 (44.04%)
Short Float %0.12%
Short Ratio0.45
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-263.04%
Min EPS beat(2)-296.04%
Max EPS beat(2)-230.03%
EPS beat(4)1
Avg EPS beat(4)-182.3%
Min EPS beat(4)-296.04%
Max EPS beat(4)43.42%
EPS beat(8)1
Avg EPS beat(8)-114.18%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-19.34%
Min Revenue beat(2)-27.15%
Max Revenue beat(2)-11.52%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.58%
PT rev (3m)23.74%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-424.74%
EPS NY rev (3m)-275%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.78
P/FCF N/A
P/OCF N/A
P/B 7.09
P/tB 7.09
EV/EBITDA N/A
EPS(TTM)-0.18
EYN/A
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0.16
BVpS0.09
TBVpS0.09
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -23.33%
ROE -84.09%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 17.42%
FCFM N/A
ROA(3y)-21.76%
ROA(5y)-29.6%
ROE(3y)-67.54%
ROE(5y)-77.36%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y43.19%
F-Score4
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 78.25%
Cap/Sales 18.81%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.59
Quick Ratio 0.43
Altman-Z -2.34
F-Score4
WACC9.28%
ROIC/WACCN/A
Cap/Depr(3y)88.58%
Cap/Depr(5y)98.19%
Cap/Sales(3y)20.94%
Cap/Sales(5y)26.51%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-12.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y80.36%
EPS Next 2Y41.42%
EPS Next 3Y27.16%
EPS Next 5Y20.57%
Revenue 1Y (TTM)11.87%
Revenue growth 3Y30.77%
Revenue growth 5Y11.4%
Sales Q2Q%12.26%
Revenue Next Year46%
Revenue Next 2Y25.66%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-17.93%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1732.34%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-4.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-202.86%
OCF growth 3YN/A
OCF growth 5YN/A